News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Pfizer Inc. Sues Novartis AG Over Vfend Antifungal Patents
January 7, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - Pfizer Inc (PFE.N) has sued Novartis AG's (NOVN.VX) Sandoz unit, accusing it of infringing its U.S. patents related to the antifungal treatment Vfend.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Pfizer
Novartis
MORE ON THIS TOPIC
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
·
6 min read
·
Lori Ellis
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
·
5 min read
·
Annalee Armstrong
Complete response letters
FDA Publishes Cache of Complete Response Letters in Bid for ‘Radical Transparency’
July 10, 2025
·
2 min read
·
Dan Samorodnitsky
Government
Kennedy Postpones Preventive Care Panel Meeting After ‘Double-Edged Sword’ Supreme Court Win
July 10, 2025
·
2 min read
·
Tristan Manalac
